#Prevention

Judge’s ruling could limit access to free HIV pre-exposure prophylaxis, cancer screenings and more.

This ruling will affect millions and erect barriers to care, say patient advocacy groups representing those with cancer, HIV and more.

The Texas ruling builds on a case in which a plaintiff objected, on religious grounds, to providing free HIV prevention PrEP to employees.

Monoclonal antibodies used to prevent COVID-19 in immunocompromised people aren’t active against new virus variants.

Plus: Over 10 prevention services related to hepatitis, HIV and sexually transmitted infections covered by the Affordable Care Act.

Plus, a court ruling has the potential to invalidate required free screenings, including for breast, colorectal, cervical and lung cancer.

The ruling centered on PrEP as HIV prevention but could apply to cancer screenings and other services and drugs.

With further testing, the antiviral proteins might be used as a nasal spray to prevent or treat COVID-19.

A federal court judge in Florida said the Centers for Disease Control and Prevention had overstepped its authority.

COVID-19 had an “immense impact” on HIV, hepatitis and STI screening, prevention and care.

Public health officials are recommending that people upgrade from their cloth masks to higher-quality medical-grade masks.

New vaccine approach triggers neutralizing antibody production and T-cell responses and lowers risk of infection.

Post-exposure and pre-exposure prophylaxis could be a game-changer for immunocompromised people.

Some studies suggest aspirin therapy may also help lower the risk of colorectal cancer.